Screening and Risk Factors for Alopecia

Article Sidebar

PDF
Published: Dec 19, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i12-38
Keywords:
alopecia, hair loss, telogen effluvium, pattern hair loss, dermatoscopy, treatment, risk factors, prevention.

Main Article Content

José María Revilla Apodaca
IMSS Hospital General de Zona No. 5, Nogales, Sonora
Ángel Ignacio Garza Zamora
IMSS Hospital General de Zona No. 5, Nogales, Sonora
Diego Mendoza Contreras
IMSS Hospital General de Zona No. 5, Nogales, Sonora

Abstract

Alopecia, characterized by the loss of hair in various patterns and extents, presents a diverse spectrum of
conditions with distinct etiologies and therapeutic considerations. This comprehensive review explores
the common types of alopecia encountered in primary care, including telogen effluvium, male- and
female-pattern hair loss, alopecia areata, traction alopecia, and tinea capitis. Diagnostic approaches
encompass careful history-taking, physical examination, and, when needed, advanced techniques like
dermatoscopy. Treatment strategies vary based on the type of alopecia, ranging from topical applications
to systemic therapies. Understanding risk factors such as age, genetics, ethnicity, and medication
associations is pivotal for tailored interventions. The prevention of specific types of alopecia involves
targeted measures, such as wearing cooling caps during chemotherapy to minimize hair loss. By
considering these factors, individuals and healthcare providers can collaboratively navigate alopecia,
optimizing patient outcomes and quality of life.

Article Details

How to Cite
Apodaca, J. M. R., Zamora, Ángel I. G. ., & Contreras, D. M. (2023). Screening and Risk Factors for Alopecia. International Journal of Medical Science and Clinical Research Studies, 3(12), 3136–3138. https://doi.org/10.47191/ijmscrs/v3-i12-38
Issue
Vol. 3 No. 12 (2023): Volume 03 Issue 12 December 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Martins, G., Doche, I., Freitag, L. A., Miteva, M., & Damasco, P. (2023). Alopecia. In Dermatology in Public Health Environments: A Comprehensive Textbook (pp. 1757-1787). Cham: Springer International Publishing.

II. Nanda, S., De Bedout, V., & Miteva, M. (2019). Alopecia as a systemic disease. Clinics in dermatology, 37(6), 618-628.

III. Buckland, M., Jaglowicz, A., Stewart, D., & Kellawan, K. (2018). Evaluation of Hair Loss in a Primary Care Setting. Primary Care Reports, 24(11).

IV. Dhurat, R., & Agrawal, S. (2023). Hair Loss and Hair Disorders. Essentials for Aesthetic Dermatology in Ethnic Skin: Practice and Procedure.

V. Lin, J., Saknite, I., Valdebran, M., Balu, M., Lentsch, G., Williams, J. N., ... & Atanaskova Mesinkovska, N. (2019). Feature characterization of scarring and non‐scarring types of alopecia by multiphoton microscopy. Lasers in surgery and medicine, 51(1), 95-103.

VI. Ramos, P. M., Melo, D. F., Radwanski, H., Almeida, R. F. C. D., & Miot, H. A. (2023). Female-pattern hair loss: therapeutic update. Anais Brasileiros de Dermatologia, 98, 506-519.

VII. Gupta, A. K., & Talukder, M. (2022). Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?. Journal of cosmetic dermatology, 21(5), 1841-1848.

VIII. Trüeb, R. M., & Dias, M. F. R. G. (2018). Alopecia areata: a comprehensive review of pathogenesis and management. Clinical reviews in allergy & immunology, 54, 68-87.

IX. Chidrawar, V. R., & Rao, U. TRACTION ALOPECIA: A REVIEW.

X. Kanti, V., Constantinou, A., Reygagne, P., Vogt, A., Kottner, J., & Blume‐Peytavi, U. (2019). Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases. Journal of the European Academy of Dermatology and Venereology, 33(10), 1976-1983.

XI. Coleman, E. (2020). Types and treatment of hair loss in men and women. Plastic and Aesthetic Nursing, 40(4), 222-235.

XII. Henne, S. K., Nöthen, M. M., & Heilmann-Heimbach, S. (2023). Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology. Medizinische Genetik, 35(1), 3-14.

XIII. Gregory, C. W., Hamil, K. G., Kim, D., Hall, S. H., Pretlow, T. G., Mohler, J. L., & French, F. S. (1998). Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer research, 58(24), 5718-5724.

XIV. Yip, L., Zaloumis, S., Irwin, D., Severi, G., Hopper, J., Giles, G., ... & Ellis, J. (2009). Gene‐wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. British Journal of Dermatology, 161(2), 289-294.

XV. Maymone, M. B., Laughter, M., Pollock, S., Khan, I., Marques, T., Abdat, R., ... & Vashi, N. A. (2021). Hair aging in different races and ethnicities. The Journal of Clinical and Aesthetic Dermatology, 14(1), 38.

XVI. Tosti, A., & Pazzaglia, M. (2007). Drug reactions affecting hair: diagnosis. Dermatologic clinics, 25(2), 223-231.

XVII. Quesada, S., Guichard, A., & Fiteni, F. (2021). Cancer-related alopecia: from etiologies to global management. Cancers, 13(21), 5556.